Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Earnings
Adial Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Nov 13, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
–
EPS, Q2 FY2026
-$11.25
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Adial Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 17, 2026before the open | – | – | -$11.25 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026before the open | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 6, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 14, 2025before the open | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 15, 2025before the open | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 4, 2025before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023after the close | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 21, 2023before the open | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 12, 2023after the close | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 31, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 15, 2022before the open | – | – | $0.12 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 16, 2022during market hours | – | – | -$0.16 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022before the open | – | – | $0.13 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Adial Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Adial Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Adial Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- News
- Results
- Update
- Update
- Results
- Results
- Update
- News
- News
- News
- Results
- Update
- Results
- News